Metraipolis › archive › dc_d77f41b75063

Immune Control, HBsAg Loss or Flare Requiring Liver Transplant-Diverse Outcomes After Stopping NUC Therapy — Europe PMC PMID:42797857

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42797857
DOI
10.3390/v18091026
License (as archived)
solo-consultazione
Archived
2026-10-15T13:50:19.894Z
SHA-256 of the archived text
3ab94ccff68e5a6c8bcc97a3dd0f59033e45fd40c932f8770d39d50f88a0dfeb
Stable URL of this page
https://metraipolis.com/documento/dc_d77f41b75063

How to cite

Immune Control, HBsAg Loss or Flare Requiring Liver Transplant-Diverse Outcomes After Stopping NUC Therapy — Europe PMC PMID:42797857 — Europe PMC (en), https://europepmc.org/article/MED/42797857 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d77f41b75063 (Metraipolis archive dc_d77f41b75063, sha256 3ab94ccff68e5a6c8bcc97a3dd0f59033e45fd40c932f8770d39d50f88a0dfeb)
BibTeX
@misc{dcd77f41b75063,
  title = {Immune Control, HBsAg Loss or Flare Requiring Liver Transplant-Diverse Outcomes After Stopping NUC Therapy — Europe PMC PMID:42797857},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42797857},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d77f41b75063; sha256 3ab94ccff68e5a6c8bcc97a3dd0f59033e45fd40c932f8770d39d50f88a0dfeb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42797857. Agents can read the archived copy with the MCP tool read_document.